Viavi Solutions has reported robust revenue and profit growth driven by strong demand in AI data centers, optical testing, and aerospace & defense sectors. The company’s data center operations, particularly in 1.6T and CPO technologies, are key growth drivers alongside steady aerospace & defense revenue. Despite a higher stock valuation, the analyst rates Viavi Solutions as a Buy at $37, expecting margin expansion and accelerated growth in core segments. Risks include reliance on AI capital expenditure cycles, customer concentration, and weak free cash flow, but positive earnings forecasts through FY2028 support the optimistic outlook.
Bitdeer Technologies Group has issued a notice asking journalists and readers to disregard a previously released news statement about Bitdeer AI securing 60MW at its Cyberjaya, Malaysia facility and reaching 95% of its 350MW target capacity. This ret...
SpaceX is expanding its AI infrastructure to support its rocket launches, Starlink satellite network, and future AI growth plans. Analysts show mixed but generally positive sentiment, with Morgan Stanley maintaining a Buy rating and a $300 price targ...
Byrna Technologies reported a fiscal Q3 loss of $0.13 per share, better than the expected $0.16 loss, but revenue fell 46% year-over-year to $15.3 million, missing estimates. The company shifted from net income to a $2.9 million net loss due to weake...
On October 8, 2026, several stocks including AngioDynamics, Apimeds Pharmaceuticals US, and Arqit Quantum experienced steep declines of over 18%, despite some positive financial reports. Leveraged ETFs CRWG and IRE also dropped 15.5%, highlighting th...
On October 8, 2026, Pacira BioSciences surged 44.4% following Viatris' agreement to acquire the company for $36.50 per share, valuing the deal at approximately $1.65 billion. Other notable gainers included Profound Medical, which rose 21.7% after for...
